文献速递乳腺技术与安全US

基于主成分回归的超声造影评估系统用于BI-RADS US 4A乳腺肿物管理:为放射科医生提供客观辅助

Principal component regression-based contrast-enhanced ultrasound evaluation system for the management of BI-RADS US 4A breast masses: objective assistance for radiologists.
PubMed 文献 · Ultrasound Med Biol · 2021-04-08

该前瞻性研究连续纳入238例病理证实的BI-RADS US 4A乳腺肿物患者,构建基于主成分分析和逻辑回归的超声造影评估系统(PCR-CEUS),并在训练集和测试集中验证其鉴别良恶性的性能。结果显示PCR-CEUS诊断性能稳定,联合资深或初级放射科医生可提高AUC和敏感度,且不降低特异度,提示该系统有助于4A肿物的客观评估。

要点

  • PCR-CEUS对BI-RADS US 4A乳腺肿物有良好鉴别能力,训练集AUC 0.831,测试集AUC 0.798。
  • PCR-CEUS联合资深医生较单独资深医生提高敏感度(0.875 vs. 0.729),特异度不降。
  • PCR-CEUS联合初级医生较单独初级医生显著提高AUC(0.852 vs. 0.665)和特异度。

局限性

  • 单中心前瞻性研究,样本量有限。
  • PCR-CEUS基于主成分分析和逻辑回归建模,需外部验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

A portion of detected breast masses might be overrated by using the Breast Imaging-Reporting and Data System ultrasonography (BI-RADS US) lexicon. A principal component regression-based contrast-enhanced ultrasound (PCR-CEUS) evaluation system was built to quantitatively illustrate whether CEUS could help radiologists to differentiate 4A masses. The PCR-CEUS evaluation system, based on principal component analysis (PCA) and logistic regression, was verified by random assignment into training and test sets and shown to reduce the data dimension and avoid collinearity in CEUS variables. This prospective study consecutively collected 238 patients with 238 4A masses confirmed pathologically. All enrolled patients accepted CEUS examination. The diagnostic performance of senior and junior radiologists, PCR-CEUS and combined methods was compared. The PCR-CEUS system had consistent diagnostic performance in both the training and test sets, with an area under the curve (AUC) of 0.831 (0.765-0.897), 0.798 (0.7034-0.892) and 0.854 (0.765-0.943) (all P > 0.05). The AUC of the combined diagnostic model (PCR-CEUS + Senior radiologists) was higher than that of senior radiologists, and the combined model had higher sensitivity (0.875 (0.781-0.969) vs. 0.729 (0.603-0.855)) without compromising specificity. Furthermore, the AUC and specificity of the combined model (PCR-CEUS + Junior radiologists) (0.852 (0.787-0.916)) was higher than that of junior radiologists (0.665 (0.592-0.737) (P < 0.00001)). PCR-CEUS demonstrated good ability in differentiating malignant BI-RADS-US 4A masses and was helpful for both senior and junior radiologists.

来源:Ultrasound Med Biol,查看原文。版权归原作者所有。

引用

  1. Lin ZM, Chen JF, Xu FT, et al. Principal component regression-based contrast-enhanced ultrasound evaluation system for the management of BI-RADS US 4A breast masses: objective assistance for radiologists. Ultrasound Med Biol. 2021. PMID: 33838937. doi:10.1016/j.ultrasmedbio.2021.02.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。